Biostar Pharmaceuticals, Inc. (BSPM)

Market Cap	264.00 +8,700.0%
Revenue (ttm)	317.79K -91.9%
Net Income	934.35K
EPS	0.34
Shares Out	2.64M
PE Ratio	0.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,386
Open	0.000001
Previous Close	0.0001
Day's Range	0.000001 - 0.0001
52-Week Range	0.000001 - 0.0001
Beta	-4,440.79
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Biostar Pharmaceuticals

Biostar Pharmaceuticals, Inc. develops, manufactures, and markets pharmaceutical products for various diseases and conditions in the People’s Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides OTC products, such as Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2007
• Employees: 200
• Stock Exchange: OTCMKTS
• Ticker Symbol: BSPM

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 10, 2026

Data Sources Report a data error